Source: Eur Respir J, 50 (1) 1700846; 10.1183/13993003.00846-2017
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vincent Cottin. Combined pulmonary fibrosis and emphysema: bad and ugly all the same?. Eur Respir J, 50 (1) 1700846; 10.1183/13993003.00846-2017

Member's Comments

No comment yet.

Related content which might interest you: Combined pulmonary fibrosis and emphysema: A distinct entity? Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Communicating with patients with idiopathic pulmonary fibrosis: can we do it better? Source: ERJ Open Res, 8 (1) 00422-2021; 10.1183/23120541.00422-2021 Year: 2022 Idiopathic pulmonary fibrosis: time for greater expectations? Source: Eur Respir J, 52 (2) 1801312; 10.1183/13993003.01312-2018 Year: 2018 Combined pulmonary fibrosis and emphysema: a high-pressure situation Source: Eur Respir J 2010; 35: 9-11 Year: 2010 Severe idiopathic pulmonary fibrosis: what can be done? Source: Eur Respir Rev, 26 (145) 170047; 10.1183/16000617.0047-2017 Year: 2017 The therapy of idiopathic pulmonary fibrosis: what is next? Source: Eur Respir Rev, 28 (153) 190021; 10.1183/16000617.0021-2019 Year: 2019 Reply to: Malnutrition in idiopathic pulmonary fibrosis: the great forgotten comorbidity! Source: Eur Respir J, 53 (5) 1900615; 10.1183/13993003.00615-2019 Year: 2019 Persistent atelectasis: then what? Source: Annual Congress 2010 - Paediatric Grand Round: an interactive session Year: 2010 Combination therapy in idiopathic pulmonary fibrosis: the way ahead will be hard Source: Eur Respir J 2015; 45: 1208-1210 Year: 2015 Real-life experience with pirfenidon in idiopathic pulmonary fibrosis: Does early treatment start predict better therapy adherence? Source: International Congress 2015 – IPF: from bench to bedside Year: 2015 The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018 Home spirometry for idiopathic pulmonary fibrosis: ready for prime time? Source: Eur Respir J, 50 (1) 1701403; 10.1183/13993003.01403-2017 Year: 2017 Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005 Acute exacerbation in combined pulmonary fibrosis and emphysema (CPFE): what special features? Source: Virtual Congress 2020 – Possible scenarios in the challenging future of rare diffuse parenchymal lung diseases Year: 2020 Combined pulmonary fibrosis and emphysema (CPFE): How does cohabitation affect respiratory functions? Source: International Congress 2017 – ILDs: clinical problems Year: 2017 Pulmonary hypertension and chronic lung disease: where are we headed? Source: Eur Respir Rev, 28 (153) 190065; 10.1183/16000617.0065-2019 Year: 2019 Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020